Market Closed -
Nyse
16:00:02 2024-05-01 EDT
|
5-day change
|
1st Jan Change
|
71.88
USD
|
+1.13%
|
|
-1.16%
|
+8.69%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
46,874
|
42,253
|
52,564
|
56,782
|
48,949
|
51,259
|
-
|
-
|
Enterprise Value (EV)
1 |
46,874
|
42,253
|
52,564
|
76,220
|
56,093
|
151,851
|
143,434
|
153,359
|
P/E ratio
|
8.41
x
|
8.27
x
|
8.55
x
|
24.9
x
|
36.5
x
|
8.71
x
|
7.73
x
|
7.14
x
|
Yield
|
3.41%
|
3.88%
|
3.04%
|
2.74%
|
3.12%
|
2.99%
|
3.09%
|
3.29%
|
Capitalization / Revenue
|
0.7
x
|
0.64
x
|
0.75
x
|
0.75
x
|
0.68
x
|
0.69
x
|
0.67
x
|
0.63
x
|
EV / Revenue
|
0.7
x
|
0.64
x
|
0.75
x
|
1.01
x
|
0.78
x
|
2.06
x
|
1.87
x
|
1.89
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
6.18
x
|
17.6
x
|
18.1
x
|
-
|
EV / FCF
|
-
|
-
|
4.17
x
|
-
|
-
|
29.1
x
|
21.1
x
|
-
|
FCF Yield
|
-
|
-
|
24%
|
-
|
-
|
3.43%
|
4.75%
|
-
|
Price to Book
|
0.74
x
|
0.6
x
|
0.81
x
|
2.43
x
|
1.84
x
|
1.85
x
|
1.64
x
|
1.47
x
|
Nbr of stocks (in thousands)
|
919,631
|
899,949
|
841,160
|
784,606
|
740,190
|
713,119
|
-
|
-
|
Reference price
2 |
50.97
|
46.95
|
62.49
|
72.37
|
66.13
|
71.88
|
71.88
|
71.88
|
Announcement Date
|
20-02-05
|
21-02-03
|
22-02-02
|
23-02-01
|
24-01-31
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
66,974
|
66,465
|
70,244
|
75,548
|
71,715
|
73,762
|
76,900
|
80,932
|
EBITDA
1 |
-
|
-
|
-
|
-
|
9,080
|
8,607
|
7,941
|
-
|
EBIT
1 |
7,559
|
8,120
|
11,000
|
8,221
|
8,362
|
8,385
|
8,326
|
8,666
|
Operating Margin
|
11.29%
|
12.22%
|
15.66%
|
10.88%
|
11.66%
|
11.37%
|
10.83%
|
10.71%
|
Earnings before Tax (EBT)
1 |
6,795
|
6,927
|
8,126
|
2,859
|
2,162
|
7,981
|
8,524
|
9,016
|
Net income
1 |
5,721
|
5,191
|
6,353
|
2,354
|
1,380
|
5,909
|
6,313
|
6,573
|
Net margin
|
8.54%
|
7.81%
|
9.04%
|
3.12%
|
1.92%
|
8.01%
|
8.21%
|
8.12%
|
EPS
2 |
6.060
|
5.680
|
7.310
|
2.910
|
1.810
|
8.257
|
9.301
|
10.07
|
Free Cash Flow
1 |
-
|
-
|
12,596
|
-
|
-
|
5,210
|
6,807
|
-
|
FCF margin
|
-
|
-
|
17.93%
|
-
|
-
|
7.06%
|
8.85%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
60.53%
|
85.73%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
198.27%
|
-
|
-
|
88.17%
|
107.82%
|
-
|
Dividend per Share
2 |
1.740
|
1.820
|
1.900
|
1.980
|
2.060
|
2.151
|
2.224
|
2.368
|
Announcement Date
|
20-02-05
|
21-02-03
|
22-02-02
|
23-02-01
|
24-01-31
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
17,087
|
20,211
|
17,724
|
18,298
|
23,690
|
15,836
|
16,126
|
18,634
|
15,866
|
18,718
|
17,016
|
18,277
|
18,689
|
19,094
|
18,683
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,917
|
2,353
|
2,500
|
2,357
|
1,576
|
1,788
|
1,857
|
2,221
|
2,288
|
1,996
|
2,095
|
2,341
|
2,448
|
2,521
|
-
|
Operating Margin
|
17.07%
|
11.64%
|
14.11%
|
12.88%
|
6.65%
|
11.29%
|
11.52%
|
11.92%
|
14.42%
|
10.66%
|
12.31%
|
12.81%
|
13.1%
|
13.2%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
1,306
|
715
|
-2
|
419
|
1,727
|
257
|
430
|
534
|
941
|
1,045
|
2,007
|
2,240
|
2,268
|
-
|
Net income
1 |
1,521
|
1,176
|
606
|
103
|
331
|
1,314
|
14
|
370
|
422
|
574
|
800
|
1,482
|
1,552
|
1,606
|
1,508
|
Net margin
|
8.9%
|
5.82%
|
3.42%
|
0.56%
|
1.4%
|
8.3%
|
0.09%
|
1.99%
|
2.66%
|
3.07%
|
4.7%
|
8.11%
|
8.31%
|
8.41%
|
8.07%
|
EPS
2 |
1.770
|
1.390
|
0.7300
|
0.1300
|
0.4100
|
1.660
|
0.0200
|
0.4800
|
0.5600
|
0.7700
|
1.100
|
2.081
|
2.194
|
2.271
|
2.259
|
Dividend per Share
2 |
0.4800
|
0.4800
|
0.4800
|
0.5000
|
0.5000
|
0.5000
|
0.5000
|
0.5200
|
-
|
0.5200
|
0.5167
|
0.5383
|
0.5383
|
0.5420
|
0.5400
|
Announcement Date
|
21-11-03
|
22-02-02
|
22-05-04
|
22-08-03
|
22-11-02
|
23-02-01
|
23-05-03
|
23-08-02
|
23-11-01
|
24-01-31
|
24-05-01
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
19,438
|
7,144
|
100,592
|
92,175
|
102,100
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
0.7868
x
|
11.69
x
|
11.61
x
|
-
|
Free Cash Flow
1 |
-
|
-
|
12,596
|
-
|
-
|
5,210
|
6,807
|
-
|
ROE (net income / shareholders' equity)
|
13.1%
|
11.9%
|
16.6%
|
12.3%
|
13.6%
|
14.7%
|
15.3%
|
15.5%
|
ROA (Net income/ Total Assets)
|
0.8%
|
0.68%
|
0.82%
|
0.78%
|
0.82%
|
1.05%
|
1.1%
|
1.2%
|
Assets
1 |
713,965
|
767,899
|
777,411
|
302,765
|
168,684
|
562,734
|
573,940
|
547,777
|
Book Value Per Share
2 |
68.60
|
78.70
|
77.10
|
29.80
|
35.90
|
38.90
|
43.80
|
49.00
|
Cash Flow per Share
|
-
|
12.70
|
14.50
|
16.30
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
-
|
-
|
2,979
|
3,066
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
4.04%
|
3.99%
|
-
|
Announcement Date
|
20-02-05
|
21-02-03
|
22-02-02
|
23-02-01
|
24-01-31
|
-
|
-
|
-
|
Last Close Price
71.88
USD Average target price
82.31
USD Spread / Average Target +14.51% Consensus |
1st Jan change
|
Capi.
|
---|
| +8.69% | 50.69B | | +10.00% | 76.32B | | +2.51% | 48.13B | | +10.78% | 42.08B | | +8.28% | 39.7B | | +19.86% | 38.01B | | +3.08% | 29.79B | | -7.02% | 27.63B | | -20.54% | 24.06B | | +10.38% | 22.72B |
Other Life & Health Insurance
|